Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Infectious Disease
•
Tuberculosis
•
Inflammatory eye disorders
•
Scleritis
•
Ophthalmology
•
General Infectious Disease
•
Primary Care
How do you approach treatment of tuberculous scleritis in pregnancy?
Related Questions
What are your vaccine recommendations while patients are on biologics?
Do you recommend boric acid for patients with recurrent candida vulvovaginitis?
Do you routinely recommend transition to dual PO antibiotic coverage for strep species and MRSA, for patients with purulent cellulitis and in the absence of culture data?
What factors should guide the choice between fosfomycin and nitrofurantoin for uncomplicated cystitis, given the reduced efficacy of fosfomycin?
Do you recommend chronic oral suppressive antibiotics after initial intensive treatment of 6-8 weeks in patients with culture-negative prosthetic joint or bone infections with retained hardware?
What specific criteria or patient conditions would make you hesitant to use fluoroquinolones early in the treatment course for managing MSSA joint infections with oral antibiotics?
How do you manage resistant infections that persist after stopping antibiotic therapy in patients with non-CF bronchiectasis?
What are your top takeaways from ID Week 2024?
How do you approach the management of recurrent episcleritis in a patient with RA that is otherwise well-controlled?
How do you approach management of DMARDs and biologics in a patient with active RA, but frequent recurrent simple UTIs?
